Background
==========

Lung cancer is one of the leading causes of cancer-related deaths in the world. The mechanism of lung carcinogenesis is not understood. Although it is well known that smoking is the primary risk factor for lung cancer, lung cancer develops in less than 20% of people who smoke throughout their life. Moreover, lung cancer is a multi-cellular and multistage process involving a number of genetic changes in oncogenes, suggesting that genetic factors may play an important role in its development.

The glutathione S-transferases (GSTs) are a gene superfamily of phase II metabolic enzymes that detoxify free radicals, particularly in tobacco smoke, products of oxidative stress, and carcinogens such as benzopyrene and other polycyclic aromatic hydrocarbons \[[@b1-medscimonit-20-1239]\]. *GSTM1* has been mapped to the GST mu gene cluster on chromosome 1p13.3. One variant in *GSTM1* has been identified: a deletion. The deletion (*GSTM1* null variant) has been examined extensively in epidemiologic studies. Persons with a homozygous deletion of the *GSTM1* locus have no enzymatic functional activity. Phenotype assays have confirmed this lack of function by demonstrating a strong concordance between phenotype and genotype \[[@b2-medscimonit-20-1239]\]. Previous studies have suggested that individuals with null genotypes of *GSTM1* may be unable to eliminate electrophilic carcinogens efficiently and have a high risk of lung cancer. However, the results from previous reported studies in Asians were inconclusive \[[@b3-medscimonit-20-1239]--[@b33-medscimonit-20-1239]\]. Therefore, we conducted a meta-analysis to explore the effect of *GSTM1* null genotype on lung cancer risk in Asians.

Material and Methods
====================

Selection of published studies
------------------------------

We searched the PubMed and EMBASE to identify published case-control studies investigating the associations of *GSTM1* null genotype with risk of lung cancer in Asians. We used the following terms: 'glutathione S-transferases' or 'GSTM1' and 'lung cancer', without restriction on language. Additional studies were identified by a manual search of references of original studies or review articles. The inclusion criteria were: (1) original papers containing independent data; (2) studies should provide the sample size, odds ratios (ORs), and 95% confidence intervals (CIs), as well as the genetic distribution or the information needed to infer the results; and (3) case-control or cohort studies. The major exclusion criteria for studies were: (1) overlapping data; (2) insufficiently useful data; and (3) case-only studies or family-based studies; (4) reviews, abstracts, or commentaries; (5) not relevant to lung cancer or GSTM1; and (6) not conducted in Asians.

Data extraction
---------------

Two independent researchers extracted raw data according to the inclusion criteria. The following information was collected from each study using a data extraction form: the surname of the first author, year of publication, country of origin, sex of subjects, histology, smoking status, number of cases and controls, adjustment, and ORs and the corresponding 95% confidence intervals (CIs) of lung cancer risk.

Statistical analysis
--------------------

For the *GSTM1* gene, we estimated the risk effect of the null genotype on lung cancer compared with the non-null genotypes in the recessive model (null *vs.* heterozygous + wild type). The strength of the association between the *GSTM1* gene and lung cancer risk was measured by ORs with 95% CIs.

The ORs with corresponding 95% CIs from individual studies were pooled using fixed or random effects models, according to the heterogeneity. When the *P* value for Cochran's Q statistic was less than 0.1, and a significant heterogeneity existed across the included studies, the random effects model (DerSimonian and Laird method) was used for meta-analysis, or the fixed-effects model (Mantel-Haenszel method) was used. Sensitivity analysis was further performed by excluding a single study to assess the impact of an individual study on the pooled estimate. Subgroup analyses were stratified by sex, histology, and smoking status. Cumulative meta-analysis was also performed. Funnel plots and Egger's regression test were used to assess the potential publication bias \[[@b34-medscimonit-20-1239]\]. Data analysis was performed using STATA 12 (StataCorp LP, College Station, Texas, USA).

Results
=======

Study characteristics
---------------------

The flow chart shown in [Figure 1](#f1-medscimonit-20-1239){ref-type="fig"} summarizes the study selection process. A total of 31 studies were retrieved based on the search criteria for lung cancer susceptibility related to the *GSTM1* polymorphism \[[@b3-medscimonit-20-1239]--[@b33-medscimonit-20-1239]\]. The main study characteristics are summarized in [Table 1](#t1-medscimonit-20-1239){ref-type="table"}. There are 5347 lung cancer cases and 6072 controls.

Meta-analysis results
---------------------

The evaluations of the association between *GSTM1* polymorphism and lung cancer risk are summarized in [Table 2](#t2-medscimonit-20-1239){ref-type="table"}. The null genotype of *GSTM1* was associated with a significantly increased risk of lung cancer when compared with present genotype (OR=1.43; 95% CI, 1.30--1.58; [Figure 2](#f2-medscimonit-20-1239){ref-type="fig"}). Fifteen studies reported adjusted ORs. The combination of adjusted ORs for lung cancer was 1.38 (95% CI, 1.23--1.54).

When stratified by sex, significantly elevated risks were observed in men (OR=1.38; 95% CI, 1.06--1.78) and women (OR=1.30; 95% CI, 1.03--1.64). In the subgroup analysis according to histology, significantly increased risks were observed in adenocarcinoma (OR=1.27; 95% CI, 1.05--1.55) and squamous cell carcinoma (OR=1.40; 95% CI, 1.10--1.78), but not in small-cell lung cancer (OR=1.22; 95% CI, 0.81--1.83). Subgroup analysis based on the smoking status showed that increased risks were found in non-smokers (OR=1.49; 95% CI, 1.25--1.79) and smokers (OR=1.78; 95% CI, 1.43--2.23).

As shown in [Figure 3](#f3-medscimonit-20-1239){ref-type="fig"}, significant associations were evident with each addition of more data over time. The results showed that the pooled ORs tended to be stable. A single study involved in the meta-analysis was deleted each time to reflect the influence of the individual data set on the pooled ORs, and the corresponding pooled ORs were not materially altered ([Figure 4](#f4-medscimonit-20-1239){ref-type="fig"}).

Funnel plot and Egger's test were used to assess the publication bias of the literature. [Figure 5](#f5-medscimonit-20-1239){ref-type="fig"} shows the funnel plot for the assessment of publication bias. The shape of the funnel plot did not reveal any evidence of obvious asymmetry ([Figure 5](#f5-medscimonit-20-1239){ref-type="fig"}). Egger's test did not show evidence of publication bias (*P*=0.09).

Discussion
==========

The present meta-analysis, including 5347 lung cancer cases and 6072 controls from 31 case-control studies, explored the association of *GSTM1* null genotype with lung cancer risk. We demonstrated that the null genotype of *GSTM1* was associated with a significantly increased lung cancer risk in Asians. Furthermore, in the stratified analysis by sex, we found that both men and women with *GSTM1* null genotype had increased lung cancer risk. However, it should be noted that the numbers of these studies were small. More studies are needed to assess the association between *GSTM1* null genotype and lung cancer risk in males and females. Cigarette smoking is a pro-inflammatory stimulus and an important risk factor for lung cancer. Some studies explored the interaction between *GSTM1* genotype and smoking habits. Our results showed significant associations between *GSTM1* polymorphism and lung cancer risk among smokers and non-smokers. We also found that patients with *GSTM1* null genotype had increased non--small-cell lung cancer (adenocarcinoma and squamous cell carcinoma) risk. However, we failed to find a significant relationship between *GSTM1* null polymorphism and small-cell lung cancer risk. This result suggested that *GSTM1* null polymorphism may play an important role in the development of non-small-cell lung cancer.

GSTs are biotransformation enzymes, and they are phase II enzymes with both catalytic activities and non-catalytic functions. Previous studies have shown that individuals with the *GSTM1* null genotype have a decreased capacity to detoxify certain carcinogens. Thus, impaired *GSTM1* function may lead to serious DNA damage and carcinogenesis. Thus, it is biologically plausible that the *GSTM1* null genotype may increase risk of lung cancer.

Our study had some advantages. First, the methodological issues for meta-analysis such as one-way sensitivity analysis and cumulative meta-analysis were well investigated. Second, the main result remained statistically significant when the adjusted ORs were combined.

Results from one-way sensitivity analysis and cumulative meta-analysis suggested high stability and reliability of our results and significant heterogeneity was not observed in this meta-analysis. Moreover, funnel plots and Egger's tests were used to find potential publication bias. The results indicated that there was no significant publication bias.

Some limitations in our meta-analysis should be mentioned. First, the numbers of published studies were not sufficient for a comprehensive analysis. Second, lack of the original data from the eligible studies limited the evaluation of the effects of the gene-gene and gene-environment interactions in the development of lung cancer. Third, only published studies were included in this meta-analysis; therefore, publication bias may have occurred even though the statistical test did not show it.

Conclusions
===========

In conclusion, this meta-analysis suggests that an increased risk of lung cancer was associated with the null polymorphism of *GSTM1* in Asians.
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###### 

Characteristics of the case-control studies included in this meta-analysis

  First author   Year   Country   Sex                                                         Histology                                                   Smoking                                                     Case   Control   Adjustment
  -------------- ------ --------- ----------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------- ------ --------- ------------
  Kihara         1995   Japan     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Smoker                                                      97     185       No
  Ge             1995   China     Mixed                                                       Mixed                                                       NA                                                          89     25        No
  Hong           1998   Korea     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   NA                                                          85     63        No
  Gao            1998   China     Mixed                                                       Mixed                                                       Mixed                                                       70     46        No
  Gao            1999   China     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   59     132       No
  Kiyohara       2000   Japan     Mixed                                                       Mixed                                                       Mixed                                                       86     88        Yes
  Lan            2000   China     Mixed                                                       Mixed                                                       Mixed                                                       122    122       Yes
  London         2000   China     Men                                                         Mixed                                                       Mixed                                                       232    710       Yes
  Chen           2001   China     Mixed                                                       Mixed                                                       Mixed                                                       106    106       No
  Xue            2001   China     Mixed                                                       Mixed                                                       Mixed                                                       106    106       No
  Lu             2002   China     Mixed                                                       Mixed                                                       Mixed                                                       314    320       No
  Kiyohara       2003   Japan     Women                                                       Mixed                                                       Nonsmoker                                                   158    259       Yes
  Wang           2003   Japan     Mixed                                                       AD                                                          Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   112    119       Yes
  Chan-Yeung     2004   China     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed                                                       130    117       Yes
  Chen           2004   China     Mixed                                                       Mixed                                                       Mixed                                                       97     197       No
  Yang           2004   China     Women                                                       Mixed                                                       Mixed                                                       200    144       No
  Gu             2004   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   180    224       No
  Li             2004   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   217    200       No
  Li             2005   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   99     66        Yes
  Lee            2006   Korea     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed                                                       171    196       Yes
  Chang          2006   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   163    163       No
  Osawa          2007   Japan     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   113    121       Yes
  Yang           2007   Korea     Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed                                                       318    353       Yes
  Jin            2010   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   150    150       Yes
  Zheng          2010   China     Mixed                                                       Mixed                                                       Mixed                                                       265    307       No
  Zhu            2010   China     Women                                                       Mixed                                                       Nonsmoker                                                   160    160       Yes
  Kiyohara       2012   Japan     Mixed                                                       Mixed                                                       Mixed                                                       462    379       Yes
  Li             2012   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   217    198       Yes
  Liu            2012   China     Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   360    360       No
  Chen           2012   China     Mixed                                                       Mixed                                                       Mixed[\*](#tfn1-medscimonit-20-1239){ref-type="table-fn"}   200    200       No
  Wang           2012   China     Mixed                                                       Mixed                                                       Mixed                                                       209    256       Yes

More information can be extracted.

AD -- adenocarcinoma.

###### 

Detailed results of meta-analysis.

                   Test of association   Heterogeneity          
  ---------------- --------------------- --------------- ------ ------
  Overall          1.43 (1.30--1.58)     \<0.00001       0.06   30.0
  Men              1.38 (1.06--1.78)     0.02            0.78   0.0
  Women            1.30 (1.03--1.64)     0.03            0.24   28.0
  Adenocarcinoma   1.27 (1.05--1.55)     0.02            0.49   0.0
  SCC              1.40 (1.10--1.78)     0.006           0.48   0.0
  SCLC             1.22 (0.81--1.83)     0.35            0.18   38.0
  Non-smoker       1.49 (1.25--1.79)     \<0.00001       0.87   0.0
  Smoker           1.78 (1.43--2.23)     \<0.00001       0.37   8.0

SCC -- squamous cell carcinoma; SCLC -- small-cell lung cancer.
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